Open an account

Myomo

MYO · NYSE American

$1.26+$0.01 (+0.80%)TodayMarket closed ·
Prev close $1.25

About MYO

Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. The company is headquartered in Boston, Massachusetts and currently employs 194 full-time employees. The company went IPO on 2017-06-12. The firm develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

Employees
194
Headquarters
Boston, Massachusetts
Listed
Jun 12, 2017
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
myomo.com

MYO key statistics

Market cap
49.91M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
293.98K
Volume
177.24K
Open price
$1.23
High today
$1.33
Low today
$1.21
52 Week high
$1.89
52 Week low
$0.605

Myomo (MYO) at a glance

Myomo (MYO) last traded at $1.26, with a market cap of 49.91M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.21 and $1.33. The current price is 4.1% above the day's low and 5.3% below its high.

Volume so far is 177.24K shares, below the average of 293.98K shares a day.

Over the past year Myomo has ranged from $0.605 to $1.89, and now sits 51% of the way up that range.

Myomo met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported -$0.12 per share against an estimate of -$0.101.

The average analyst price target is $4.64, 268.3% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 5 analystsAvg $4.64
Low
$1.72
Now
$1.26
High
$11.02

MYO earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 31.1% on average.

  1. Q3 FY24: reported -$0.03 per share against an estimate of -$0.0421
  2. Q4 FY24: reported -$0.01 per share against an estimate of -$0.0202
  3. Q1 FY25: reported -$0.08 per share against an estimate of -$0.0768
  4. Q2 FY25: reported -$0.11 per share against an estimate of -$0.1071
  5. Q3 FY25: reported -$0.09 per share against an estimate of -$0.1091
  6. Q4 FY25: reported -$0.085 per share against an estimate of -$0.0869
  7. Q1 FY26: reported -$0.05 per share against an estimate of -$0.1151
  8. Q2 FY26: reported -$0.12 per share against an estimate of -$0.101

MYO news

  • Press releaseBusiness Wire

    Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer

  • Press releaseBusiness Wire

    Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Press releaseBusiness Wire

    Myomo Reports Second Quarter 2026 Financial and Operating Results

  • Press releaseBusiness Wire

    Myomo to Report Second Quarter 2026 Financial Results on August 5

  • Press releaseBusiness Wire

    Myomo Announces Participation in iAccess Alpha Virtual Best Ideas Summer Investment Conference

  • Press releaseBusiness Wire

    Myomo Announces Participation in Upcoming Investor Conferences

Similar companies

Companies in the same industry as Myomo

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.